COX-2 selective NSAID medication
Clinical data | |
---|---|
Trade names | Soleton |
Other names | Zaxoprofen |
Drug class | NSAID |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.070.863 |
Chemical and physical data | |
Formula | C17H14O3S |
Molar mass | 298.36 g·mol |
3D model (JSmol) | |
|
Zaltoprofen (JAN; trade name Soleton) is: a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent. It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.
It was approved for use in Japan in 1993.
References※
- ^ "Zaltoprofen". drugs.com.
- ^ Hirate K, "Uchida A," Ogawa Y, "Arai T," Yoda K (April 2006). "Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors". Neuroscience Research. 54 (4): 288–94. doi:10.1016/j.neures.2005.12.016. PMID 16473424. S2CID 27367042.
- ^ "Zaltoprofen Launched in Japan". thepharmaletter.com. September 20, 1993.